Lineage Cell Therapeutics
LCTX
#8900
Rank
ยฃ79.45 M
Marketcap
ยฃ0.34
Share price
-6.12%
Change (1 day)
-61.39%
Change (1 year)

EPS for Lineage Cell Therapeutics (LCTX)

EPS in 2023 (TTM): -ยฃ0.11

According to Lineage Cell Therapeutics 's latest financial reports the company's current EPS (TTM) is -ยฃ0.09670. In 2022 the company made an earnings per share (EPS) of -ยฃ0.11 an increase over its 2021 EPS that were of -ยฃ0.19.

EPS history for Lineage Cell Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ0.11-2.66%
2022-ยฃ0.11-42.31%
2021-ยฃ0.1985.71%
2020-ยฃ0.10250%
2019-ยฃ0.02975-88.57%
2018-ยฃ0.26105.88%
2017-ยฃ0.13-153.13%
2016ยฃ0.24-154.24%
2015-ยฃ0.445.36%
2014-ยฃ0.42-30.86%
2013-ยฃ0.6088.37%
2012-ยฃ0.3219.44%
2011-ยฃ0.2733.33%
2010-ยฃ0.2068.75%
2009-ยฃ0.12-5.88%
2008-ยฃ0.13183.33%
2007-ยฃ0.04463-25%
2006-ยฃ0.05951-27.27%
2005-ยฃ0.08182-38.89%
2004-ยฃ0.1338.46%
2003-ยฃ0.09670-43.48%
2002-ยฃ0.17-26.63%
2001-ยฃ0.23-28.75%
2000-ยฃ0.33-13.73%
1999-ยฃ0.38
1997-ยฃ0.253.13%
1996-ยฃ0.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-ยฃ1.62 1,576.92%๐Ÿ‡บ๐Ÿ‡ธ USA